Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A combination of Deferoxamine mesylate and minimally invasive surgery with hematoma lysis for evacuation of intracerebral hemorrhage.

Literature DB >> 31791162

A combination of Deferoxamine mesylate and minimally invasive surgery with hematoma lysis for evacuation of intracerebral hemorrhage.

Aditya S Pandey¹, Badih J Daou¹, Neeraj Chaudhary¹, Guohua Xi¹.

Abstract

Entities: Chemical Disease

Keywords: Deferoxamine; hematoma lysis; intracerebral hematoma evacuation; intracerebral hemorrhage

Mesh：

Substances：
Deferoxamine

Year: 2019 PMID： 31791162 PMCID： PMC7370622 DOI： 10.1177/0271678X19892660

Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN： 0271-678X Impact factor: 6.200

× No keyword cloud information.

10 in total

1. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.

Authors: Magdy Selim; Lydia D Foster; Claudia S Moy; Guohua Xi; Michael D Hill; Lewis B Morgenstern; Steven M Greenberg; Michael L James; Vineeta Singh; Wayne M Clark; Casey Norton; Yuko Y Palesch; Sharon D Yeatts
Journal: Lancet Neurol Date: 2019-03-18 Impact factor: 44.182

2. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.

Authors: Daniel F Hanley; Richard E Thompson; Michael Rosenblum; Gayane Yenokyan; Karen Lane; Nichol McBee; Steven W Mayo; Amanda J Bistran-Hall; Dheeraj Gandhi; W Andrew Mould; Natalie Ullman; Hasan Ali; J Ricardo Carhuapoma; Carlos S Kase; Kennedy R Lees; Jesse Dawson; Alastair Wilson; Joshua F Betz; Elizabeth A Sugar; Yi Hao; Radhika Avadhani; Jean-Louis Caron; Mark R Harrigan; Andrew P Carlson; Diederik Bulters; David LeDoux; Judy Huang; Cully Cobb; Gaurav Gupta; Ryan Kitagawa; Michael R Chicoine; Hiren Patel; Robert Dodd; Paul J Camarata; Stacey Wolfe; Agnieszka Stadnik; P Lynn Money; Patrick Mitchell; Rosario Sarabia; Sagi Harnof; Pal Barzo; Andreas Unterberg; Jeanne S Teitelbaum; Weimin Wang; Craig S Anderson; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Wendy Ziai; Mario Zuccarello; Issam A Awad
Journal: Lancet Date: 2019-02-07 Impact factor: 79.321

Review 3. Hematoma clearance as a therapeutic target in intracerebral hemorrhage: From macro to micro.

Authors: D Andrew Wilkinson; Richard F Keep; Ya Hua; Guohua Xi
Journal: J Cereb Blood Flow Metab Date: 2018-01-19 Impact factor: 6.200

4. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.

Authors: J C Hemphill; D C Bonovich; L Besmertis; G T Manley; S C Johnston
Journal: Stroke Date: 2001-04 Impact factor: 7.914

5. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA).

Authors: O P M Teernstra; S M A A Evers; J Lodder; P Leffers; C L Franke; G Blaauw
Journal: Stroke Date: 2003-03-20 Impact factor: 7.914

Review 6. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.

Authors: Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn
Journal: Lancet Neurol Date: 2010-01-05 Impact factor: 44.182

7. Unmet Needs and Challenges in Clinical Research of Intracerebral Hemorrhage.

Authors:
Journal: Stroke Date: 2018-04-04 Impact factor: 7.914

8. Effectiveness of endoscopic surgery for supratentorial hypertensive intracerebral hemorrhage: a comparison with craniotomy.

Authors: Xinghua Xu; Xiaolei Chen; Fangye Li; Xuan Zheng; Qun Wang; Guochen Sun; Jun Zhang; Bainan Xu
Journal: J Neurosurg Date: 2017-04-07 Impact factor: 5.115

9. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial.

Authors: A David Mendelow; Barbara A Gregson; Elise N Rowan; Gordon D Murray; Anil Gholkar; Patrick M Mitchell
Journal: Lancet Date: 2013-05-29 Impact factor: 79.321

10. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.

Authors: Daniel F Hanley; Richard E Thompson; John Muschelli; Michael Rosenblum; Nichol McBee; Karen Lane; Amanda J Bistran-Hall; Steven W Mayo; Penelope Keyl; Dheeraj Gandhi; Tim C Morgan; Natalie Ullman; W Andrew Mould; J Ricardo Carhuapoma; Carlos Kase; Wendy Ziai; Carol B Thompson; Gayane Yenokyan; Emily Huang; William C Broaddus; R Scott Graham; E Francois Aldrich; Robert Dodd; Cristanne Wijman; Jean-Louis Caron; Judy Huang; Paul Camarata; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Neil Martin; Issam Awad; Mario Zuccarello
Journal: Lancet Neurol Date: 2016-10-11 Impact factor: 44.182

10 in total

6 in total

6. Assessing early erythrolysis and the relationship to perihematomal iron overload and white matter survival in human intracerebral hemorrhage.

Authors: Nemanja Novakovic; Zachary M Wilseck; Thomas L Chenevert; Guohua Xi; Richard F Keep; Aditya S Pandey; Neeraj Chaudhary
Journal: CNS Neurosci Ther Date: 2021-06-17 Impact factor: 5.243